Atlas Trials

A Dose Escalation Study of OMP-52M51 in Subjects With Solid Tumors

Clinical trial NCT01778439 · COMPLETED

Trial details

NCT number
NCT01778439
Sponsor
OncoMed Pharmaceuticals, Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Relapsed or Refractory Solid Tumors
Start date
2013-02-01
Primary completion
2016-07-01
Enrollment
48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.